Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

 

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

http://hdl.handle.net/11427/14992
http://dx.doi.org/10.1371/journal.pmed.1001718
 
Abstract:
Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary
Reference:
Boulle, A., Schomaker, M., May, M. T., Hogg, R. S., Shepherd, B. E., Monge, S., ... & Sterne, J. A. (2014). Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies. PLoS medicine, 11(9), e1001718. doi:10.1371/journal.pmed.1001718
 
 
Boulle, Andrew
Schomaker, Michael
May, Margaret T
Hogg, Robert S
Shepherd, Bryan E
Monge, Susana
Keiser, Olivia
Lampe, Fiona C
Giddy, Janet
Ndirangu, James
 
2014
 
Death rates
North America
Europe
South Africa
Antiretroviral therapy
HIV
AIDS
Viral load
 
Show full item record
 
 
Files in this item
 
Source
PLOS Medicince
 

This item appears in the following Collection(s)

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Except where otherwise noted, this item's license is described as This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.